Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Versartis enters commercial supply agreement with Boehringer Ingelheim Biopharmaceuticals

Thursday, December 29, 2016

Versartis - Initial term of agreement continues for period of 8 years, after initial term, agreement will automatically renew for periods of 3 years each.

Says on Dec 21, co entered into a commercial supply agreement with Boehringer Ingelheim Biopharmaceuticals GMBH.

Versartis Inc says pursuant to agreement co engaged Boehringer as a contract manufacturer to manufacture bulk drug substance for co's somavaratan (VRS-317).

magazine-slider-imageMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024Nitrosamine Advance Workshop 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024